Park Place Capital’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.1K Buy
584
+479
+456% +$40.7K 0.01% 438
2026
Q1
$9.05K Hold
105
﹤0.01% 620
2025
Q4
$9.17K Hold
105
﹤0.01% 588
2025
Q3
$6.01K Sell
105
-11
-9% -$633 ﹤0.01% 624
2025
Q2
$6.98K Hold
116
﹤0.01% 633
2025
Q1
$8.49K Buy
116
+11
+10% +$909 ﹤0.01% 614
2024
Q4
$8.69K Hold
105
﹤0.01% 594
2024
Q3
$7.51K Hold
105
﹤0.01% 658
2024
Q2
$7.19K Hold
105
﹤0.01% 666
2024
Q1
$5.63K Hold
105
﹤0.01% 725
2023
Q4
$5.59K Hold
105
﹤0.01% 712
2023
Q3
$5.21K Hold
105
﹤0.01% 848
2023
Q2
$6.25K Hold
105
﹤0.01% 835
2023
Q1
$5.95K Sell
105
-369
-78% -$23.7K ﹤0.01% 844
2022
Q4
$35K Buy
+474
New +$32.3K 0.01% 534

Other funds holding GMED

Park Place Capital's GMED Position: Q2 2026 in Review

Park Place Capital increased its Globus Medical (GMED) stake by 456% in Q2 2026, buying an estimated $40.7K and bringing the position to 584 shares worth $46.1K. The position accounts for 0.01% of the portfolio, ranked #438.

Park Place Capital first reported a position in GMED in Q4 2022 and has held it in 15 quarters since. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Park Place Capital held 584 shares of Globus Medical worth $46.1K as of Q2 2026.
  • Park Place Capital bought 479 Globus Medical shares in Q2 2026, an estimated $40.7K.
  • Globus Medical made up 0.01% of Park Place Capital's portfolio in Q2 2026, its #438 holding.
  • Park Place Capital first reported a position in Globus Medical in Q4 2022 and has held it in 15 quarters since.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.